MarketBeat's profile
Blog
Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052
Key Points
- Interested in Aclaris Therapeutics, Inc.? Here are five stocks we like better.
- Aclaris Therapeutics is preparing a packed clinical calendar, with data expected in the second half of
The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro in Focus
Key Points
- Interested in Hewlett Packard Enterprise Company? Here are five stocks we like better.
- Established technology hardware makers are successfully capturing new opportunities as the demand
Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies Conference
Key Points
- Interested in Adicet Bio, Inc.? Here are five stocks we like better.
- Adicet Bio is prioritizing its autoimmune lead program prula-cel (ADI-001), with the next update expected to
Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
Key Points
- Interested in Generac Holdings Inc.? Here are five stocks we like better.
- Generac secured a global supply agreement with an undisclosed hyperscaler on June 2, 2026, sending shares up
Medtronic Bottoms, Healthy Rebound Ahead
Key Points
- Interested in Medtronic PLC? Here are five stocks we like better.
- Medtronic is on track to rebound in the back half of 2026.
- Solid results, cash flow, and dividends point to a shift in